Aggressive B-Cell Lymphomas: Experts Discuss New Care Standards and Evolving Treatment Strategies

Get up to date on the evolving strategies for managing mantle cell lymphoma and diffuse large B-cell lymphoma and watch the on-demand webcast download slides and read an expert-authored commentary adapted from the live symposium.

Share

Program Content

Activities

Aggressive B-Cell Lymphomas
Aggressive B-Cell Lymphomas: Experts Discuss New Care Standards and Evolving Treatment Strategies
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: January 30, 2023

Expires: January 29, 2024

Activities

MCL: Risk Stratification and Treatment
MCL: Prognostic and Predictive Biomarkers for Risk Stratification and Treatment Selection for Patients
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 12, 2022

Expires: December 11, 2023

DLBCL: Biology and Initial Therapy
DLBCL: Biology, Prognosis, and Selection of Initial Therapy
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 12, 2022

Expires: December 11, 2023

DLBCL: Treatment of R/R Disease
DLBCL: Management of Primary Refractory and Relapsed/Refractory Disease
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 12, 2022

Expires: December 11, 2023

<i>EP</i>: MCL/DLBCL Therapy

Express Points

Aggressive B-Cell Lymphomas: Experts Discuss New Care Standards and Evolving Treatment Strategies

Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 16, 2022

Expires: December 15, 2023

Activities

FAQs: Aggressive B-Cell
FAQs: Optimal Selection and Sequencing of Treatment for Patients With Aggressive B-Cell Lymphomas
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: January 31, 2023

Expires: January 30, 2024

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

Genmab US Inc and AbbVie

Karyopharm Therapeutics Inc.

Regeneron Pharmaceuticals, Inc.